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Objective: This study investigated the effects of cardiopulmonary bypass on neu-
trophil expression of chemokine receptors, CXCR1 and CXCR2, and the β2 integrin
CD11b.
Methods: Ten patients undergoing coronary artery grafting with cardiopulmonary
bypass were studied. Blood samples were collected preoperatively, before bypass,
at termination of bypass, and 12 to 18 hours postoperatively. In vitro studies were
performed on control subjects to determine changes in the surface expression of
CXCR1, CXCR2, and CD11b on stimulation with interleukin 8. Receptor expres-
sion was measured by flow cytometry. Plasma levels of interleukin 8 from the
patients were determined by enzyme-linked immunoassay.
Results: After bypass, CXCR2 expression fell by 66% (P < .0001) and remained
low postoperatively (P < .0001). CXCR1 expression persisted at preoperative lev-
els. CD11b expression increased significantly after bypass (P < .0001), returning to
prebypass levels postoperatively. In vitro studies showed a dose-related fall of both
CXCR1 (P < .0001) and CXCR2 expression (P < .0001) and a significant rise in
CD11b expression (P < .0001). Plasma interleukin 8 increased significantly after
bypass (P < .0001), remaining elevated 12 to 18 hours postoperatively (P = .02).
Correlations between interleukin 8 levels and CXCR2 expression (P < .0001) and
CD11b expression (P < .03) were demonstrated.
Conclusions: CXCR2 expression is significantly down-regulated after bypass; in
contrast, CXCR1 expression remains unchanged. In addition, whereas interleukin 8
is an important determinant of both CXCR1 and CXCR2 expression in vitro, it only
correlates with CXCR2 and CD11b expression in vivo. This has implications in the
search for antagonists against CXC chemokines and their receptors
Cardiopulmonary bypass (CPB) contributes to the morbidity and mor-tality of cardiac surgery by its ability to initiate a systemic inflamma-tory response.1 Understanding the molecular mechanisms responsiblefor neutrophil leukocyte recruitment after CPB is central in develop-ing strategies to limit the adverse effects of acute inflammation.Chemokines play a central role in polymorphonuclear leukocyte
recruitment and activation. Interleukin 8 (IL-8) is a prototypical member of the CXC
group2 and has a key role in neutrophil migration and activation in animal models of
acute inflammatory disease3 and increases after CPB4 and reperfusion injuries.3
In vitro studies using IL-8 receptor antagonists have demonstrated the impor-
tance of IL-8–induced signal transduction in neutrophil migration, activation, and
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degranulation.5 The plasma concentration of IL-8 receptor
expression during CPB is therefore likely to be an important
determinant of neutrophil-induced injury after CPB. We
therefore studied the effect of CPB on the surface expres-
sion of the two principal CXC receptors (CXCR1 and
CXCR2) on polymorphonuclear leukocytes. In addition, we
examined the relationship between IL-8 receptor expression
and circulating IL-8 levels in the peribypass period.
Patients and Methods
Patients 
Ten patients undergoing elective coronary artery bypass grafting
with CPB were included in the study. The Newcastle and North
Tyneside Joint Ethics Committee approved the study, and written
informed consent was obtained from participating patients. After
surgery, a multiple organ dysfunction score and a Murray lung
injury score were determined for each patient.6,7
Anesthesia and CPB
Patients underwent standard hypothermic CPB with an extracor-
poreal membrane oxygenator (Cobe-Duo; Cobe, Denver, Colo).
After the operation, patients were transferred to the cardiac inten-
sive care unit. Ventilation and sedation (propofol and morphine
sulphate mixture) were continued until weaning and extubation.
Complications after the operation were treated appropriately
according to unit protocols.
Cytokine and Receptor Measurements 
Venous blood samples were collected at 4 time points: 24 hours
preoperatively, after induction of anesthesia but before sternotomy,
after cessation of CPB (within 30 minutes), and 12 to 18 hours
postoperatively in the intensive care unit. All samples were
obtained from internal jugular central venous lines. The first 5 mL
of blood was discarded, and samples were immediately placed on
ice before transfer and processed within 30 minutes of collection.
Antibodies 
The monoclonal antibodies (MoAbs) used were of the purified
immunoglobulin G type, and experiments included irrelevant iso-
type-matched MoAb as negative controls. MoAbs directly conju-
gated to fluorochromes were used in all studies. The anti-CD45
MoAb, PerCP-conjugate (Becton Dickinson, Cowley, United
Kingdom), recognizes the common leukocyte antigen on neu-
trophils, monocytes, and lymphocytes. MoAbs for the integrin α
chain anti-CD11b phycoerythrin conjugate (Dako Ltd, Ely,
Cambridge, United Kingdom), anti-CXCR1 phycoerythrin conju-
gate, and anti-CXCR2 fluorescein isothiocyanate conjugate (both
from R & D Systems, Abingdon, Oxford, United Kingdom) were
also used. 
Flow Cytometry 
A whole blood method was used to measure chemokine receptor
and adhesion molecule expression.8 The in vitro response of neu-
trophils to IL-8 was studied with the use of venous blood from
healthy volunteers (n = 4). Samples (100 µL) of anticoagulated
(sodium citrate, 0.105 mol/L) whole blood were incubated with
varying concentrations (0.1-100 nmol/L) of IL-8 (PeproTech EC
Ltd, London, United Kingdom) at 37ºC for 30 minutes. Control
samples of whole blood were incubated with an equal volume of
phosphate-buffered saline solution instead of IL-8. Immuno-
fluorescent flow cytometry was then used to measure CD11b,
CXCR1, and CXCR2 surface expression on neutrophils. The
patient samples obtained in the CPB study were analyzed with the
use of identical immunofluorescent staining methods.
Double-color immunofluorescent staining was analyzed by a
bench-top FACScan machine (Becton Dickinson, Cowley, United
Kingdom) using LYSYS II software. The 3 major leukocyte sub-
populations (neutrophils, lymphocytes, and monocytes) were
resolved in real time on the basis of their side light scattering and
staining intensity characteristics with the use of anti-CD45 in the
FL3 channel. The fluorescent intensity due to bound fluorescein
isothiocyanate or phycoerythrin-labeled antibody was monitored
Figure 1. In vitro effect of IL-8 stimulation on neutrophil CXC receptor and CD11b integrin expression. Whole
blood preparations were treated for 30 minutes at 37°C with varying concentrations of IL-8. Results are the mean
of 4 separate experiments ± SEM and are expressed as molecules of equivalent soluble fluorochromes
(M.E.S.F.). A, CXCR1. B, CXCR2. C, CD11b. A significant reduction in both CXCR1 and CXCR2 expression occurred
on exposure of neutrophils to IL-8; in contrast, CD11b expression increased significantly.
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simultaneously in the FL1 and FL2 channels, respectively.
Fluorescence was quantified by converting median fluorescent val-
ues into molecules of equivalent soluble fluorochrome with the use
of calibration fluorescent beads.
Plasma IL-8 Levels 
The plasma IL-8 level was measured by an enzyme-linked
immunosorbent assay technique with appropriate positive and neg-
ative controls (PharMingen, Becton Dickinson, Cowley, United
Kingdom).
Hematology 
Leukocyte and differential white cell counts were analyzed with a
cell counter (Coulter STKS Analyzer; Coulter Corporation,
Hialeah, Fla).
Statistical Analysis 
The data were analyzed via repeated-measures analysis of variance
by the Bonferroni method. Correlations between peak cytokine
concentrations or chemokine receptor expression and different
parameters were calculated with the Pearson correlation coeffi-
cient. Results are expressed as mean ± standard error of the mean
(Arcus Quickstat, Biomedical Version 1.1, Research Solution).
Results
In Vitro Studies 
Incubation of neutrophils with IL-8 produced a dose-related
fall in the expression of both CXCR1 and CXCR2 expres-
sion and a rise in CD11b expression (Figure 1). A 10-
nmol/L dose (8 × 104 pg/mL) of IL-8 resulted in a decrease
of 55% (P = .0004) in the expression of CXCR1 (Figure 1,
A) compared with control values, and a further fall in
expression (90% of control value) occurred with 100
nmol/L (8 × 105 pg/mL) IL-8 (P < .0001). In contrast,
CXCR2 (Figure 1, B) expression was only significantly
reduced on incubation with a 100-nmol/L (8 × 105 pg/mL)
concentration of IL-8 (P = .003). The expression of CD11b
(Figure 1, C) increased after exposure to 10 nmol/L (8 × 104
pg/mL) IL-8 (P = .007), and a further rise of 400% com-
pared with control values occurred with 100 nmol/L (8 ×
105 pg/mL) IL-8 (P < .0001).
Clinical Studies 
The study group comprised 6 men and 4 women with a
mean age of 63 ± 8 years, all of whom underwent coronary
artery bypass grafting. Mean CPB and aortic crossclamp
times were 95 ± 33 and 53 ± 24 minutes, respectively. All
subjects made an uneventful recovery and were extubated
within 24 hours of surgery. No patient had significant lung
injury or organ failure as indicated by low Murray and mul-
tiple organ dysfunction scores. 
The neutrophil count was significantly elevated immedi-
ately after CPB (12.8 × 109/L; P < .0001) and was still
raised 12 to 18 hours later (9.0 × 109/L; P = .0017) (normal
range for the neutrophil counts, 3.5-7.5 × 109/L). No signif-
icant change was observed in the level of expression of
CXCR1 after CPB (Figure 2, A). The level of CXCR2
expression (Figure 2, B) fell by an average of 66% after
CPB (P < .0001) and remained significantly depressed com-
pared with preoperative levels 12 to 18 hours later (P <
.0001). The expression of neutrophil CD11b (Figure 2, C)
increased by an average of 227% (P < .0001) in the post-
CPB period. This was followed by a fall in expression to
near normal preoperative values by the postoperative stage.
IL-8 levels rose significantly to 55.2 pg/mL (P < .0001) in
the immediate post-CPB period. Postoperatively, levels then
fell to 26.0 pg/mL but were still significantly higher than
preoperative values (P = .02). No correlation (P = .5) was
found between IL-8 plasma levels and CXCR1 receptor
expression. A significant correlation (r2 = 0.39, P < .0001)
was found between IL-8 levels and CXCR2 receptor expres-
sion. In addition, a significant correlation (r2 = 0.71, P =
Figure 2. Polymorphonuclear leukocyte CXC receptor and CD11b integrin expression in response to CPB. Each
point represents mean ± SEM of the 10 patients studied and is expressed as molecules of equivalent soluble flu-
orochromes (M.E.S.F.). A, CXCR1. B, CXCR2. C, CD11b. No significant change in polymorphonuclear leukocyte
CXCR1 expression occurred. CXCR2 expression fell significantly after CPB and remained reduced postopera-
tively (P < .0001). CD11b expression increased significantly (P < .0001) immediately after bypass.
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.03) was found between IL-8 levels and CD11b expression
on neutrophils. There was no significant correlation
between CXCR1, CXCR2, or CD11b expression and CPB
times, ischemic times, alveolar-arterial pressure gradients,
or organ dysfunction scores.
Discussion
We are not aware of previous studies that have investigated
the response of CXCR1 and CXCR2 during CPB. We found
that neutrophil CXCR2 expression was significantly down-
regulated after CPB and remained at a depressed level for at
least 12 to 18 hours postoperatively. The reduction in
chemokine receptor expression can be explained by inter-
nalization of the receptor-ligand complex. This allows
destruction of the ligand, receptor recycling, and a contin-
ued cellular response to the chemokine.9,10 In our study, the
interdependence of chemokine receptor and its associated
ligand is illustrated by the correlation of changes in CXCR2
expression with plasma IL-8 levels. In comparison, CXCR1
expression remained relatively unchanged throughout the
perioperative period, and no correlation with IL-8 levels was
found.
Changes in CXC receptor surface expression have
important functional consequences for neutrophil chemo-
taxis. The degree of neutrophil migration across endothelial
cell monolayers is proportional to the surface expression of
the relevant CXC receptor. A reduced expression therefore
implies a fall in migration, and this has been reported in
human sepsis.11 Our results suggest that circulating neu-
trophils are less likely to respond to CXCR2 chemokines
after CPB but will continue to respond to CXCR1
chemokines. This has important implications in the search
for antagonists to chemokines and their receptors. 
Exposure of neutrophils to increasing concentrations of
IL-8 in vitro resulted in a significant down-modulation of
both CXC receptors. This differs from our in vivo findings
but is in agreement with other in vitro studies.10,12 The com-
plex and varied neutrophil-cytokine interactions that occur
in vivo during inflammation may explain the differences. In
the standard model of neutrophil chemotaxis, neutrophil
migration is driven by gradients of soluble chemokines.
This model has been modified by Rot and colleagues,13 who
proposed that the chemokine gradients that mediate leuko-
cyte–endothelial cell adhesion and transmigration are cre-
ated by chemokines immobilized on the endothelial cell
surface. In this model, a dynamic equilibrium would exist in
vivo between the circulating pool of IL-8 and the IL-8
bound to tissues, endothelium, and red cells. Therefore, the
true concentration of IL-8 to which polymorphonuclear
leukocyte CXC receptors are exposed perioperatively would
in fact be much higher and not wholly reflected in the con-
centration of free IL-8 measured in the plasma. This could
explain our observations that the concentration of IL-8
required in vivo to down-regulate CXCRs was an order of
magnitude higher than the level measured during CPB.
In vivo neutrophils are simultaneously exposed to multi-
ple inflammatory mediators. Tumor necrosis factor α, endo-
toxin, and C5a are elevated after cardiac surgery and can
down-regulate neutrophil CXC receptor expression through
receptor cross desensitization.14-17 Tumor necrosis factor α
and C5a result in a sustained loss of CXCR2 expression,
whereas CXCR1 expression remains unaffected.15,16
Furthermore, after receptor internalization, CXCR1 is reex-
pressed on the cell surface more rapidly than CXCR2.9 A
number of these mechanisms may explain the differences in
CXC receptor expression after cardiac surgery compared
with the situation in vitro.
CD11b is part of the β2 integrin family of surface adhe-
sion molecules. These molecules mediate firm adhesion of
neutrophils to endothelium, which is a prerequisite for sub-
sequent migration into inflamed tissues.18 In vitro IL-8 pro-
duced a significant up-regulation in expression of CD11b on
exposure to increasing concentrations of IL-8, confirming
earlier reports.19 Our study demonstrated a temporary ele-
vation in CD11b expression after CPB, which rapidly
returned to near normal pre-CPB levels by 12 to 18 hours
postoperatively. This finding is consistent with previous
studies and probably reflects the transient nature of the
inflammatory stimulus.20
Changes in chemokine receptor expression on neu-
trophils are likely to be important in the pathogenesis of
post-CPB organ damage. We have shown that CXCR2 is
down-regulated in patients after CPB, whereas CXCR1
expression remains unchanged. IL-8 is an important deter-
minant of both CXCR1 and CXCR2 expression in vitro but
only correlates with CXCR2 expression in the more com-
plex clinical situation.
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